Wuhan Hiteck Biological Pharma Co.,Ltd
SZSE:300683.SZ
46.4 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 510.216 | 748.478 | 184.05 | 460.822 | 695.592 | 307.07 | 697.582 | 607.984 | 496.451 | 472.226 | 174.915 |
| Short Term Investments
| 578.707 | 144.043 | 514.399 | 250.391 | 479.57 | 956.55 | 750 | -4.994 | 40 | 0 | 0 |
| Cash and Short Term Investments
| 1,088.923 | 892.521 | 698.449 | 711.213 | 1,175.162 | 307.07 | 697.582 | 607.984 | 496.451 | 472.226 | 174.915 |
| Net Receivables
| 265.878 | 255.037 | 289.561 | 247.937 | 229.675 | 244.226 | 278.057 | 272.542 | 195.988 | 217.766 | 166.998 |
| Inventory
| 117.414 | 120.181 | 71.652 | 69.632 | 56.583 | 34.506 | 22.448 | 14.99 | 22.227 | 25.276 | 25.179 |
| Other Current Assets
| 15.984 | 176.394 | 522.858 | 299.512 | 7.129 | 959.842 | 750.788 | 0.589 | 40 | -1.215 | -3.222 |
| Total Current Assets
| 1,488.199 | 1,444.133 | 1,582.52 | 1,328.293 | 1,468.548 | 1,545.643 | 1,748.875 | 896.104 | 754.665 | 714.053 | 363.87 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 734.559 | 654.226 | 519.626 | 348.63 | 271.135 | 222.495 | 107.085 | 97.991 | 76.013 | 57.581 | 50.985 |
| Goodwill
| 263.591 | 302.151 | 316.169 | 316.448 | 275.678 | 275.398 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 298.665 | 91.38 | 90.187 | 95 | 63.793 | 66.108 | 18.19 | 18.78 | 19.51 | 20.314 | 21.069 |
| Goodwill and Intangible Assets
| 562.256 | 393.531 | 406.356 | 411.448 | 339.471 | 341.506 | 18.19 | 18.78 | 19.51 | 20.314 | 21.069 |
| Long Term Investments
| -551.628 | -55.155 | -449.108 | -245.391 | 13.529 | 15.524 | 11.565 | 7.843 | -17.439 | 0 | 0 |
| Tax Assets
| 109.472 | 80.098 | 71.639 | 57.627 | 32.831 | 27.736 | 20.584 | 16.051 | 14.744 | 3.159 | 1.635 |
| Other Non-Current Assets
| 628.392 | 189.529 | 566.48 | 285.959 | 43.995 | 2.451 | 2.451 | 2.451 | 25 | 6.263 | 3.506 |
| Total Non-Current Assets
| 1,483.052 | 1,262.228 | 1,114.992 | 858.273 | 700.96 | 609.714 | 159.877 | 143.117 | 117.828 | 87.318 | 77.195 |
| Total Assets
| 2,971.251 | 2,706.361 | 2,697.512 | 2,186.566 | 2,169.509 | 2,155.357 | 1,908.752 | 1,039.22 | 872.493 | 801.37 | 441.065 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 52.079 | 58.052 | 51.718 | 50.602 | 45.202 | 13.829 | 8.024 | 6.833 | 5.913 | 7.584 | 4.397 |
| Short Term Debt
| 29.235 | 59.149 | 59.22 | 6.487 | 17.557 | -33.732 | -7.015 | -15.007 | -14.339 | 0 | 0 |
| Tax Payables
| 5.66 | 8.309 | 8.588 | 4.96 | 5.205 | 9.896 | 20.017 | 13.653 | 9.562 | 7.491 | 9.264 |
| Deferred Revenue
| 258.357 | 167.361 | 138.193 | 310.139 | 49.564 | 33.732 | 7.015 | 15.007 | 14.339 | 0 | 0 |
| Other Current Liabilities
| 6.475 | 0.172 | 0.117 | 0.078 | 273.266 | 417.33 | 247.525 | 318.939 | 263.578 | 254.302 | 179.167 |
| Total Current Liabilities
| 346.146 | 284.734 | 249.249 | 367.307 | 385.589 | 431.159 | 255.549 | 325.772 | 269.491 | 261.886 | 183.564 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 36.721 | 43.504 | 51.807 | 5.446 | 2.451 | 2.451 | 2.451 | 2.451 | -0 | 0 | 0 |
| Deferred Revenue Non-Current
| 30.468 | 27.897 | 22.591 | 21.942 | 4.958 | 6.223 | 7.488 | 7.473 | 6.041 | 2.893 | 2.857 |
| Deferred Tax Liabilities Non-Current
| 16.48 | 12.618 | 7.253 | 7.943 | 5.772 | 5.939 | 0.137 | 0.17 | 0.206 | 0 | 0 |
| Other Non-Current Liabilities
| 45.916 | 2.451 | 23.556 | 58.982 | 10.258 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 129.584 | 86.47 | 105.208 | 94.313 | 23.438 | 14.613 | 10.076 | 10.094 | 6.247 | 2.893 | 2.857 |
| Total Liabilities
| 475.73 | 371.204 | 354.457 | 461.62 | 409.027 | 445.772 | 265.625 | 335.866 | 275.738 | 264.778 | 186.421 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 130.894 | 122.104 | 122.104 | 103.355 | 103.355 | 103.355 | 103.355 | 77.516 | 77.516 | 75.924 | 64.3 |
| Retained Earnings
| 457.077 | 577.9 | 591.93 | 564.275 | 606.064 | 553.323 | 490.191 | 362.308 | 266.588 | 241.129 | 142.35 |
| Accumulated Other Comprehensive Income/Loss
| 53.264 | 53.264 | 53.264 | 53.264 | 53.264 | 53.264 | 53.264 | 257 | 251.935 | 0 | 0 |
| Other Total Stockholders Equity
| 1,836.92 | 1,557.103 | 1,557.103 | 987.757 | 989.61 | 989.61 | 989.61 | 0 | 0 | 217.503 | 46.453 |
| Total Shareholders Equity
| 2,478.155 | 2,310.371 | 2,324.401 | 1,708.652 | 1,752.293 | 1,699.552 | 1,636.42 | 696.824 | 596.039 | 534.555 | 253.103 |
| Total Equity
| 2,495.521 | 2,335.157 | 2,343.055 | 1,724.946 | 1,760.482 | 1,709.585 | 1,643.127 | 703.354 | 596.756 | 536.592 | 254.644 |
| Total Liabilities & Shareholders Equity
| 2,971.251 | 2,706.361 | 2,697.512 | 2,186.566 | 2,169.509 | 2,155.357 | 1,908.752 | 1,039.22 | 872.493 | 801.37 | 441.065 |